Carregant...

Pharmacotherapy for alcoholic patients with alcoholic liver disease

PURPOSE: An update on pharmacotherapy for achieving and maintaining abstinence and mitigating hepatic damage in patients with alcoholic liver disease (ALD) is presented. SUMMARY: Currently there are limited pharmacotherapy options for managing ALD, which encompasses a broad spectrum of disorders ran...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Vuittonet, Cynthia L., Halse, Michael, Leggio, Lorenzo, Fricchione, Samuel B., Brickley, Michael, Haass-Koffler, Carolina L., Tavares, Tonya, Swift, Robert M., Kenna, George A.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4170837/
https://ncbi.nlm.nih.gov/pubmed/25027533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2146/ajhp140028
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!